
    
      This is Randomized, Open label, Non-inferiority Study of Micafungin versus Fluconazole for
      the Korean Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients

      After transplant subjects will be randomized to one of the following treatment arms:

        -  Micafungin 100 mg/day intravenous (2.0 mg/kg/day in subjects weighing <40 kg)

        -  Fluconazole 100~200mg/day, IV care until oral medication becomes possible

      Stratification according to centers. Antifungal prophylaxis will be administered once daily
      for a period of 21 days, or until hospital discharge, whichever occurs first.

      This is an open label study; Study center personnel will not be blinded to treatment.
    
  